Cure My Disease

Don't miss your cure!

 Log in / Sign up

CT-Guided heart exams could cut radiation and time

NCT ID NCT05218694

Disease control Sponsor: Aarhus University Hospital Skejby Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 26, 2026 · Last updated Aug 27, 2026 · Updated 1 time

Summary

This trial tests whether using detailed CT images of the heart's arteries to plan invasive procedures can reduce radiation exposure, procedure time, contrast use, and tools needed. Adults with stable angina and significant blockages are randomly assigned to receive either standard care or a CT-guided approach. The goal is to see if this smarter planning makes the procedure more efficient and potentially safer.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
CCTA-guided focused coronary angiography examination
What this could lead to
If effective, this approach could make heart procedures faster, safer, and less resource-intensive.
What could go wrong
The trial is relatively small and early, so benefits may not be confirmed or widely applicable.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

122 people

The number who actually took part.

Started

May 2022

Finished

Feb 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age \> 18 and \< 81 years * Stable angina * at least 1 vessel disease in either the left coronary artery or right coronary artery * Stenosis grater than 50% and no stenosis greater than 40% on contralateral vessel unless fractional flow reserve by CT (FFRct) \>0.80 * Vessel segment \> 2 mm in diameter * Subject eligible for Dual Anti Platelet Therapy (DAPT Exclusion Criteria: * Significant bleeding risk or other contraindications against heparinization or DAPT * Known pregnancy * Life expectancy \< 120 days * Patient unable to provide informed consent * Patients with CTO (Chronic Total Occlusion).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Coronary artery disease are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

coronary artery disorder myocardial ischemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Coronary artery disease Ischemic heart disease

Contacts and locations

Locations

  • Aarhus University Hospital, Depart. of Cardiology

    Aarhus N, Central Region, 8200, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.